G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation.

Amyotrophic lateral sclerosis FUS Phenotype-genotype correlation Slow progression lower motor neuron involvement p.G507D mutation

Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
10 2022
Historique:
received: 18 08 2021
revised: 17 04 2022
accepted: 13 05 2022
pubmed: 30 6 2022
medline: 17 8 2022
entrez: 29 6 2022
Statut: ppublish

Résumé

Mutations in FUS gene have been described classically in young ALS patients with aggressive disease course. Here we report a large family carrying a missense mutation c.1520 G>A in FUS gene with a tight association with an atypical FUS-ALS phenotype. A 60-year-old man with unilateral leg involvement at onset showed very slow disease progression with selective posterior legs atrophy, tracing his aunt's disease history. His father and uncle died for ALS after a long disease course. Another patient with a 14 years history of ALS with the same phenotype, was found to belong to the same family. In all cases, genetic analysis of FUS gene revealed a missense mutation c.1520 G>A (p.G507D) inherited with a heterozygous pattern. Co-segregation of p.G507D mutation and a specific disease phenotype within the family, characterised by predominant involvement at the lower limbs, slow progression, late bulbar and respiratory failure, demonstrates pathogenicity of this mutation, establishes a well-defined genotype-phenotype correlation and expands the clinical spectrum of heterogeneity in FUS-ALS.

Identifiants

pubmed: 35768328
pii: S0197-4580(22)00114-2
doi: 10.1016/j.neurobiolaging.2022.05.006
pii:
doi:

Substances chimiques

FUS protein, human 0
RNA-Binding Protein FUS 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-128

Subventions

Organisme : Intramural NIH HHS
ID : Z01 AG000949
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Ilaria Martinelli (I)

Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero Universitaria di Modena, Modena 41126, Italy.

Elisabetta Zucchi (E)

Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, 41125, Italy. Electronic address: elibettizucchi@gmail.com.

Viviana Pensato (V)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Via Celoria 11, 20133 Milan, Italy.

Cinzia Gellera (C)

Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Via Celoria 11, 20133 Milan, Italy.

Bryan J Traynor (BJ)

Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Department of Neurology, Johns Hopkins University, Baltimore, MD, USA; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, University College London, London, UK.

Giulia Gianferrari (G)

Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, 41125, Italy.

Adriano Chiò (A)

Department of Neuroscience, ALS Center "Rita Levi Montalcini", University of Torino, Torino, Italy; Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Italy; Neuroscience Institute of Torino, Torino, Italy.

Jessica Mandrioli (J)

Neurology Unit, Department of Neuroscience, S. Agostino Estense Hospital, Azienda Ospedaliero Universitaria di Modena, Modena 41126, Italy; Department of Biomedical, Metabolic, and Neural Science, University of Modena and Reggio Emilia, Modena, 41125, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH